In a systematic review of the published literature, we find that patients with cancer have a higher chance of being s-p53 antibody-positive compared with patients without cancer, and that the ratio of the odds of a positive test result among cancer patients is approximately 6-fold the odds of a positive test result among non-cancer individuals. The gene discussed is TP53; the disease is cancer.